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The ATP synthase capacity of rat heart myocytes can be measured in sonicates of cultured cardiomyocytes. In these 
cells, transitions in ATP synthase capacity occur on changing to the anoxic or uncoupled state (drop in ATP synthase 
capacity of over 40%) or on electrically stimulating the cells to contract (rise of 70%). These changes occur rapidly (half 
time less than 1 min) and are completely reversed on returning to the original conditions. It is proposed that mitochondria 
in vivo are directly regulated at the level of the ATP synthase. T’he naturally occurring inhibitor protein from mitochon- 
dria may be responsible for this regulation. 
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1. INTRODUCTION 
The mitochondrial ATP synthase 
(F1-Fo-ATPase) (for a review see [l]) is responsible 
for the bulk of ATP synthesis in (aerobic) heart 
tissue. As energy demand changes, the flux 
through this enzyme must also change so that ATP 
synthesis matches ATP utilisation. In heart, 
5-lo-fold increases in flux are not uncommon. 
It is generally believed that the mitochondrial 
ATP synthase responds simply to ADP levels - 
that it has a high capacity relative to its turnover 
and, as ADP levels rise, the enzyme achieves a 
higher degree of saturation (and thus faster turn- 
over). This view, however, has been questioned. 
First, the ATP synthase in heart mitochondria has 
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been shown to be a potential control site since it 
has a significant control strength at physiological 
rates of ATP synthesis [2]. Secondly, a variety of 
regulatory elements have been shown to act at the 
level of the ATP synthase (for reviews see [3,4]). 
In particular, a regulator protein, IFI, has been 
identified as occurring naturally in the mitochon- 
dria of a variety of mammals [5-71. This protein 
inhibits the ATP synthase (in both the synthetic 
and hydrolytic directions) in a potential- and ATP- 
dependent manner [8,9] and its properties in sub- 
mitochondrial vesicles from ox heart have been 
well characterised [lo]. This protein would seem to 
be a good candidate for a regulator of the ATP 
synthase in vivo. 
Work by Rouslin [11,12] has supported the idea 
that this protein may inhibit the Fl-Fo-ATPase of 
heart mitochondria in some animals during periods 
of ischaemia, although no effect was found in the 
rat. We show here that modulation of ATP syn- 
thase activity, consistent with its regulation in vivo 
by such a regulator protein, does indeed occur in 
intact rat cardiac myocytes. Further, such regula- 
tion applies in conditions other than ischaemia, 
such as quiescence, stimulated contraction, anoxia 
and uncoupling. 
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2. MATERIALS AND METHODS Table 1 
Calcium-tolerant cardjomyocytes were obtained from the 
hearts of female Wistar rats by the method of Powell et al. [13]. 
Freshly isolated myocytes were cultured using the rapid cell at- 
tachment procedure of Piper et al. [14]. Briefly, polystyrene 
culture dishes (Falcon, type 3002) were preincubated overnight 
at 37°C with 4% (v/v) fetat calf serum (FCS) in medium 199 
(M199). Isolated cells, from the above procedure, were diluted 
in 4% FCS/Ml99 to about 1 x 10’ cells/ml, 3 ml added to the 
precoated culture dishes and incubated for 4 h at 37’C. Under 
these conditions, live cells attached to the plates and dead cells 
could be removed by aspiration. 
ATP synthase capacity in cultured cardiomyocytes exposed to 
metabolic transitions 
After attachment, the proportion of rod shaped (i.e. viable) 
celis was >95% and cellular ATP was 37.9 nmol/mg protein, 
in agreement with [14]. Cells in culture were stable for several 
days. Cultured cells, obtained after an attachment period of 
4 h, were used in the experiments described below. 
Petri dishes with attached myocytes (typically 1 x lo5 cells 
per dish) were washed twice with buffer I [25 mM Hepes, 
110 mM NaCl, 2.6 mM KCl, 1.2 mM KHzPO+ 1.2 mM 
MgSOd, 1 mM CaCl2, pH 7.4 (NaOH)], and incubated in 2 ml 
of this buffer with appropriate additions (see text). For ATPase 
assay, buffer I was replaced by buffer II [20 mM Hepes, 1 mM 
MgC12, 2 mM EGTA, pH 7.0 (NaOH)], and the cells im- 
mediately sonicated 3 x 10 s at 2.5’C using an MSE probe 
sonicator (150 W) at 1Opm amplitude. (This neutral, low salt 
buffer was chosen for cell disintegration as IF, is displaced 
from F1 at high salt or high PH.) ATPase activity and NADH 
oxidase activity were measured as previously [lo] except that 
2 mM EGTA replaced EDTA in the reaction medium. Under 
these conditions, >90% of the measured ATPase was 
mitochondrial as shown by sensitivity to oligomycin and azide. 
Neither FCCP nor carboxyatractylate affected the ATPase ac- 
tivity measured, confirming that the mitochondrial membranes 
were fully broken. Protein was measured according to 1151. 
Treatment ATPase activity NADH oxidase 
of cells &moi/min per mg activity &mol/min 
protein) per mg protein} 
02 3.7 f 0.3 0.10 i 0.01 
NZ 2.3 + 0.1 0.11 i- 0.02 
FCCP 1.5 * 0.1 0.11 * 0.01 
Stimulation 6.5 r 0.4 0.13 * 0.02 
Cultured myocytes (I x lo5 cells/plate) were prepared, and 
incubated in 2 ml buffer I (see section 2) gassed with 100% OZ. 
Their mitochondrial ATPase capacity was measured after 
sonication, as described in section 2. Where indicated, 02 was 
replaced with 100% N2 for 15 min, or the cells were incubated 
with 2 PM FCCP, or stimulated electrically (20 V/cm at 3 Hz, 
0.5 ms per pulse) for 2 min. Results are expressed as mean * 
SD (n > 7) 
Collagenase (Worthington Type 1, Ci. histo~tjc#~) was ob- 
tained from Lorne Laboratories (Twyford, England). For cell 
isolations, purified bovine serum albumin (Behringwerke, Mar- 
burg, FRG) or Pentex bovine albumin, fraction V (Miles 
Laboratories, Naperville, IL, USA) was used. Ml99 and fetal 
calf serum were obtained from Boehringer (Mannheim, FRG). 
synthase capacity falls from 100% (3.7 pmol/min 
per mg protein) to 63 % . This appears to be related 
to the energy state of the mitochondria, since in- 
cubating the cells with uncoupler (table 1) or 
cyanide (data not shown) prior to sonication leads 
to an even greater drop in synthase capacity. (Note 
that addition of uncoupler to the ATPase assay 
medium does not affect turnover rate: these obser- 
vations relate to effects on the cells themselves.) In 
contrast, electrical stimulation of these myocytes 
(leading to contraction) leads to a 70% increase in 
mitochondrial ATP synthase activity. Thus, when 
energy demand in the cell increases, the ATP syn- 
thase is switched on. 
3. RESULTS 
As previously [lo], we have used ATP hydrolysis 
at saturating [ATP] as a measure of ATP synthase 
capacity, since the synthase works in both 
hydrolytic and synthetic directions. If the ATP 
synthase, in the cells, is activated (and this ac- 
tivated state is stable to sonication, etc.), sub- 
mitochondrial vesicles derived from these cells will 
have an increased ATPase activity. 
To eliminate the possibility that these transients 
reflect changes in mitochondrial recovery rather 
than activity, NADH oxidase activity was 
monitored in the same extracts as a mitochondrial 
marker. Table 1 shows that this activity was con- 
stant at around 0.1 ymol/min per mg irrespective 
of which pretreatment was involved. It was con- 
cluded that mitochondri~ recovery was constant, 
and that the observed differences did indeed reflect 
changes in ATP synthase activation. 
Table 1 shows that, as the metabolic state of 
myocytes is changed, the capacity of their 
mitochondri~ ATP synthase changes. When cells 
are shifted from the quiescent, oxygenated state to 
an oxygen-free buffer (100% Nz, anoxia), the ATP 
These changes in ATP synthase capacity occur- 
red rapidly and were rapidly reversed. This is 
demonstrated for electrically stimuiated cells in 
fig. 1. The half time for activation following com- 
mencement of stimulation was about 40 s, and 
after cessation of stimulation, the mitochondria 
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Fig. 1. Time course of changes in ATP synthase capacity. Cultured cardiomyocytes were mcubated in buffer I (see section 2) and their 
mitochondrial ATPase activity measured after electrical stimulation as described in table 1, except that samples were taken after 
various periods of stimulation, or after cessation of stimulation as indicated. 100% = 6.5 pmol/min per mg protein (see table 1). 
reverted to their original state within about 2 min. 
In fact, the changes themselves probably took 
place faster than this, but there appeared to be an 
initial lag. This is clearly visible in the inactivation 
profile, and may also be present during activation 
(fig.1). This may represent the creation of, and 
recovery from an ‘energy debt’ within the cells dur- 
ing contraction. Similarly rapid inactivation and 
recovery is seen in the oxygenated-anoxic- 
oxygenated transition (data not shown). 
4. DISCUSSION 
We show above that the mitochondrial ATP 
synthase, in cultured rat heart cells, changes in 
capacity with their metabolic state. During elec- 
trical stimulation, the synthase is switched to a 
more active state; when oxygen is removed, or the 
system uncoupled (such that the ATP synthase 
could hydrolyse ATP in vivo), the enzyme is swit- 
ched off (table 1). These changes are rapidly rever- 
sible inside the cells (fig.l), as would be required of 
a regulatory mechanism. Down regulation of heart 
mitochondrial ATPase in ischaemia has been 
demonstrated by Rouslin in species other than rat 
[ll, 121, and it has been proposed that this inhibi- 
tion may limit futile hydrolysis of ATP in 
ischaemia. However, the present findings are the 
first demonstration that the mitochondrial ATP 
synthase in any species can be regulated in vivo in 
other than pathological situations, and that this 
regulation is rapid and reversible. 
Since the regulated states of the ATP synthase 
are stable to dilution of broken mitochondria into 
a large volume of assay buffer, a rapidly reversi- 
ble, allosteric mechanism with a small molecular 
regulator is ruled out. The results are, however, 
compatible with the participation of a protein 
regulator, the mitochondrial ATPase inhibitor 
protein IFr. This protein binds to the Fr portion of 
the mitochondrial ATP synthase, inhibiting its 
(synthetic and hydrolytic) activities [9]. It has been 
shown to regulate the activity of the Fr-Fo-ATP 
synthase in ox heart submitochondrial vesicles [lo] 
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and a homologous protein has been demonstrated 
in the rat [6]. It is thus proposed that mitochon- 
drial ATP synthase in rat heart in vivo may be 
regulated by varying its association with a natural- 
ly occurring inhibitor protein, IFr. 
Some of the properties of the regulation observ- 
ed are consistent with the known properties of the 
Fr-IFr interaction from ox heart mitochondria - 
for example the time course of the change and the 
promotion of inhibition at low membrane 
energisation [9, IO]. The effect of electrical stimula- 
tion cannot be so simply explained, however, and 
must await further experimentation. However, it is 
possible that intramitochondrial Ca2+ might affect 
the Fi-IF1 interaction in this situation. 
Whatever the mechanism, these results run 
counter to the generally accepted view of the 
regulation of ATP synthesis in vivo. Typically, it 
is believed that the ATP synthase is not regulated 
(its capacity is unchanged) with varying metabolic 
conditions, and that it responds to increasing ATP 
demand simply by responding to increasing ADP 
levels - the normal response of an (unsaturated) 
enzyme to increasing substrate. This view cannot 
account for the changes in ATP synthase capacity 
observed above: these clearly demonstrate that 
some direct regulation of the ATP synthase does 
occur within intact cells. 
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